Steven A. Shallcross - 29 Dec 2022 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Signature
/s/ Steven A. Shallcross
Issuer symbol
TOVX
Transactions as of
29 Dec 2022
Net transactions value
+$43,700
Form type
4
Filing time
03 Jan 2023, 05:04:27 UTC
Previous filing
16 Dec 2022
Next filing
23 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOVX Common Stock Purchase $43,700 +100,000 +1000% $0.4370 110,000 29 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.